Brief: Schott Pharma Q2 Revenues Up 11% YoY To Eur 274 Mln

SCHOTT Pharma AG & Co KgaA

27/06/2024 06:05

June 27 (Reuters) - SCHOTT PHARMA AG & CO KGAA
 1SXP.DE :
    * CONTINUES GROWTH PATH IN THE SECOND QUARTER OF FISCAL YEAR
2024
    * Q2 REVENUES UP 11% YOY TO EUR 247M AT CONSTANT CURRENCIES
    * Q2 EBITDA MARGIN OF 27.0% AT CONSTANT CURRENCIES
    * GUIDANCE FOR FISCAL YEAR 2024 CONFIRMED
    * EBITDA DECLINED SLIGHTLY COMPARED TO PRIOR YEAR AS
EXPECTED DUE
TO RAMP-UP COST FROM CONTINUED INVESTMENTS IN CAPACITY EXPANSION
    * REVENUES AND EBITDA ON A REPORTED BASIS WERE IMPACTED BY
STRONG
CURRENCY HEADWINDS IN Q2

Source text for Eikon:  ID:nEQ8vHmSsa 
Further company coverage:  1SXP.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))